Structure-based design of thienobenzoxepin inhibitors of pi3-kinase Deposition Author(s): Murray, J.M. , Wiesmann, C.
Date: 2011-03-22 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Homo Sapiens Sequences Data: 3R7R_A
The development of peptide-based tools for the analysis of angiogenesis Deposition Author(s): Murray, J.M. , Wiesmann, C.
Date: 2011-05-14 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 3S1B_V , 3S1B_A
The development of peptide-based tools for the analysis of angiogenesis Deposition Author(s): Murray, J.M. , Wiesmann, C.
Date: 2011-05-15 Method: X-RAY DIFFRACTION Resolution: 2.55 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 3S1K_A , 3S1K_B , 3S1K_V , 3S1K_W
Rational design of pi3k-alpha inhibitors that exhibit selectivity over the pi3k-beta isoform Deposition Author(s): Murray, J.M. , Wiesmann, C.
Date: 2011-08-01 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 3T8M_A
Discovery of gdc-0980: a potent, selective, and orally available class i phosphatidylinositol 3-kinase (pi3k)/mammalian target of rapamycin (mtor) kinase inhibitor for the treatment of cancer Deposition Author(s): Murray, J.M. , Wiesmann, C.
Date: 2011-08-29 Method: X-RAY DIFFRACTION Resolution: 2.788 Å Organism(s): Homo Sapiens Sequences Data: 3TL5_A
Crystal structure of the immunoreceptor tigit igv domain Deposition Author(s): Bazan, J.F. , Rouge, L. , Stengel, K.F. , Wiesmann, C. , Yin, J.P.
Date: 2011-10-27 Method: X-RAY DIFFRACTION Resolution: 2.627 Å Organism(s): Homo Sapiens Sequences Data: 3UCR_A , 3UCR_B , 3UCR_C , 3UCR_D
Crystal structure of the immunoreceptor tigit in complex with poliovirus receptor (pvr/cd155/necl-5) d1 domain Deposition Author(s): Bazan, F.J. , Rouge, L. , Stengel, K.F. , Wiesmann, C. , Yin, J.P.
Date: 2011-10-28 Method: X-RAY DIFFRACTION Resolution: 2.903 Å Organism(s): Homo Sapiens Sequences Data: 3UDW_A , 3UDW_B , 3UDW_C , 3UDW_D
Discovery of novel allosteric mek inhibitors possessing classical and non-classical bidentate ser212 interactions. Deposition Author(s): Belvin, M. , Boggs, J. , Burton, B. , Chan, E. , Chan, J. , Choo, E. , Gancia, E. , Heald, R. , Jackson, P. , Jones, M. , Merchant, M. , Newman, R. , Price, S. , Savy, P. , Ultsch, M. , Wiesmann, C.
Date: 2011-12-07 Method: X-RAY DIFFRACTION Resolution: 2.705 Å Organism(s): Homo Sapiens Sequences Data: 3V01_A
Discovery of novel allosteric mek inhibitors possessing classical and non-classical bidentate ser212 interactions. Deposition Author(s): Belvin, M. , Boggs, J. , Burton, B. , Chan, E. , Chan, J. , Choo, E. , Gancia, E. , Heald, R. , Jackson, P. , Jones, M. , Merchant, M. , Newman, R. , Price, S. , Savy, P. , Ultsch, M. , Wiesmann, C.
Date: 2011-12-07 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Homo Sapiens Sequences Data: 3V04_A
Mouse malt1(caspase-ig3 domains) in complex with a irreversible peptidic inhibitor Deposition Author(s): Renatus, M. , Wiesmann, C.
Date: 2011-12-15 Method: X-RAY DIFFRACTION Resolution: 3.15 Å Organism(s): Mus Musculus , Synthetic Construct Sequences Data: 3V4L_A , 3V4L_B